Annual Gene Therapy Symposium for
Heart, Lung, and Blood Diseases
Home
Information for
Trainees
Register Online
2017
Past Symposia:
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002

UC Davis

 


7th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases
Focus Topic: Preclinical Studies
November 19-21, 2008 - Sonoma, California

Program

 
 

Wednesday, November 19, 2008 - Welcoming Reception

  

Barry J. Byrne, M.D., Ph.D.Thursday, November 19, 2008

Keynote Speaker

  • Barry J. Byrne,, M.D. Ph.D. (University of Florida)
    “Pathways to Clinical Studies in Gene Therapy: The Critical Role of Preclinical Models in Molecular Medicine”

 

Session I  

  • Kenneth G. Cornetta, M.D. (Indiana University)
    “The Challenges of Generating Clinical Grade Lentiviral Production”
  • James M. Wilson, M.D., Ph.D. (University of Pennsylvania)
    “Viral Infections, Vaccines, and Gene Therapy”
  • Nancy Smyth Templeton, Ph.D. (Baylor College of Medicine)
    “Optimization of Non-Viral Vectors for Preclinical Studies”
Student/Fellow Presentations and Poster Session - Link to Information

Session II   

  • Roger J. Hajjar, M.D. (Mount Sinai School of Medicine)
    “Clinical Gene Therapy for Heart Failure”

  • Joseph C. Wu, MD, Ph.D. (Stanford University)
    “Molecular Imaging of Cardiac Gene Therapy”
  • Mervin C. Yoder, M.D. (Indiana University)
    “New Insights into Methods to Identify Circulating Endothelial Cells and Hematopoietic Progenitor Cells that Represent the Circulating Cells Involved in Cardiovascular Disease”

“Practical Strategies”: Tissue Engineering and the Challenges of Translating to Human Applications

  • Gordana V. Vunjak-Novakovic Ph.D. (Columbia University)


Friday, November 21, 2008

Workshop: “Preclinical Consideration for Gene Therapy Products: CBER Perspective”

  • Mercedes Serabian, M.S., D.A.B.T.
    (FDA, CBER, OCTGT)

Session III

  • Hanna K.A. Mikkola, M.D., Ph.D. (University of California, Los Angeles)
    “Defining and Recreating the Human Fetal Hematopoietic Stem Cell Microenvironment”
  • Connie J. Eaves, Ph.D. (Terry Fox Laboratory)
    “Hematopoietic Stem Cells and Their Regulation - The Devil in the Details”

  • Donald B. Kohn, M.D. (Chldrens Hospital Los Angeles)
    "Gene Therapy Using Hematopoietic Stem Cells"
Student/Fellow Presentations and Poster Session - Link to Information

Session IV

  • Bernard Thébaud, M.D., Ph.D. (University of Alberta)
    “Role of Angiogenesis During Lung Development, Injury, and Repair”

  • Joseph Zabner, M.D. (University of Iowa)
    “Generation of Novel AAV Vectors for Cystic Fibrosis Gene Therapy”





 
 

Supported by the National Heart, Lung, and Blood Institute, National Institutes of Health. Additional support provided by the National Institute of Allergy and Infectious Diseases, National Institute of Biomedical Imaging and Bioengineering, NIH; Baxter BioScience, Children's Miracle Network; California National Primate Research Center; and the UC Davis Clinical and Translational Science Center.